Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias P Domogalla

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|December 1, 2015
Tolerogenic Dendritic Cells for Regulatory T Cell Induction in ManVerena K Raker, Matthias P Domogalla, Kerstin Steinbrink
Journal of Immunology (Baltimore, Md. : 1950)|September 30, 2016
IL-10-Modulated Human Dendritic Cells for Clinical Use: Identification of a Stable and Migratory Subset with Improved Tolerogenic ActivityFanny Kryczanowsky, Verena Raker, Edith Graulich, et al.
Frontiers in Immunology|January 30, 2018
Tolerance through Education: How Tolerogenic Dendritic Cells Shape ImmunityMatthias P Domogalla, Patricia V Rostan, Verena K Raker, et al.
ACS Nano|October 11, 2016
Interleukin-2 Functionalized Nanocapsules for T Cell-Based ImmunotherapyStefanie U Frick, Matthias P Domogalla, Grit Baier, et al.
Medicines (Basel, Switzerland)|May 23, 2020
Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution ExperienceStefaan W Van Gool, Jennifer Makalowski, Erin R Bonner, et al.
Bioconjugate Chemistry|December 13, 2017
Chemoselective Dual Labeling of Native and Recombinant ProteinsBikram Keshari Agrawalla, Tao Wang, Andreas Riegger, et al.
Nature Nanotechnology|June 20, 2018
Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular coronaManuel Tonigold, Johanna Simon, Diego Estupiñán, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|December 1, 2015
Tolerogenic Dendritic Cells for Regulatory T Cell Induction in ManVerena K Raker, Matthias P Domogalla, Kerstin Steinbrink
Journal of Immunology (Baltimore, Md. : 1950)|September 30, 2016
IL-10-Modulated Human Dendritic Cells for Clinical Use: Identification of a Stable and Migratory Subset with Improved Tolerogenic ActivityFanny Kryczanowsky, Verena Raker, Edith Graulich, et al.
Frontiers in Immunology|January 30, 2018
Tolerance through Education: How Tolerogenic Dendritic Cells Shape ImmunityMatthias P Domogalla, Patricia V Rostan, Verena K Raker, et al.
ACS Nano|October 11, 2016
Interleukin-2 Functionalized Nanocapsules for T Cell-Based ImmunotherapyStefanie U Frick, Matthias P Domogalla, Grit Baier, et al.
Medicines (Basel, Switzerland)|May 23, 2020
Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution ExperienceStefaan W Van Gool, Jennifer Makalowski, Erin R Bonner, et al.
Bioconjugate Chemistry|December 13, 2017
Chemoselective Dual Labeling of Native and Recombinant ProteinsBikram Keshari Agrawalla, Tao Wang, Andreas Riegger, et al.
Nature Nanotechnology|June 20, 2018
Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular coronaManuel Tonigold, Johanna Simon, Diego Estupiñán, et al.
Pageof 1